Retatrutide: What do the studies show so far?

Can you get approved retatrutide now?

No. Retatrutide isn't approved for weight loss or diabetes. It remains a test drug that acts like three of your body's hormones. One may ease hunger. Another helps insulin control blood sugar. The third may make your body use more energy. Phase 2 asks whether a drug works, and this study included 338 adults living with obesity. Average weight loss at the top amount was 24.2 percent over 48 weeks ^[1]. That large early average can't tell you what you'll lose. Some people lost less or stopped after feeling sick. Phase 3 studies now check more people for both help and harm. A pharmacy can't fill an approved retatrutide prescription. Nausea, vomiting, and diarrhea were common. Higher amounts caused more trouble. People using vials marked "for research only" also share stories. The words on that label don't mean they joined a real study. Those reports haven't been checked in a fair test. You'll find them marked that way on the effects page.

How did retatrutide change weight and blood sugar?

Early studies found weight loss. Retatrutide is a 39-amino-acid chain, meaning a short row of protein building blocks. It takes on three hormone jobs. The hunger-and-sugar hormone, called GLP-1, may ease your hunger. After food, it helps insulin clear sugar from your blood. GLP-1 can't explain the whole drug. A second hormone adds help after you eat. The third may raise energy use and cut liver fat. That mix may explain the large Phase 2 weight change ^[1][6].

In the 48-week Phase 2 obesity study, the 12 mg group lost 24.2 percent of body weight on average. The placebo group got no retatrutide and lost 2.1 percent ^[1]. Your result might look quite different.

In a 36-week Phase 2 diabetes study, doctors checked a blood test covering about three months. At 12 mg, that test fell 2.02 percent. The placebo group had a 0.01 percent fall. Body weight fell 16.94 percent ^[2].

A different Phase 2 study looked at fatty liver. Liver fat fell 82.4 percent by 24 weeks with the largest study amount. A normal liver-fat level was reached by 86 percent ^[5].

In 2025, reviewers called the weight result a large gain over older drugs ^[6]. Here's your catch. Phase 2 care was close, and Phase 3 results aren't all in.

What happens after retatrutide enters your body?

It takes on three hormone jobs. In 2024, close-up pictures showed retatrutide attached at the cell spots used by all three ^[3]. The hunger-and-sugar hormone is called GLP-1. GLP-1 may ease hunger. After food, it helps insulin handle blood sugar. Yet GLP-1 isn't the whole drug. The third job may make your body use more energy and cut liver fat. Those jobs may help explain the greater weight loss at high study amounts ^[1][6].

The drug also has a small fat-like tail. That tail makes your blood clear it more slowly. Doctors use half-life for the point once half the drug has cleared. For retatrutide, it's about six days. That's why researchers chose one shot each week ^[4]. Your catch is simple: bad effects may take days to fade.

Is retatrutide FDA approved right now?

No. By mid-2026, the FDA hadn't approved retatrutide. Other drug agencies hadn't cleared the drug either. It remains in Phase 3, the last large round of tests. The TRIUMPH-1 Phase 3 study checks weight loss ^[7]. Another Phase 3 study includes people with heart disease ^[8]. A third follows kidney and heart health over time ^[9]. One more compares retatrutide with tirzepatide ^[10].

Early results can't win approval by themselves. The maker must finish Phase 3 and give the FDA all its proof in an approval request. FDA staff then weigh the help against the harm. A usual review can last 6–12 months after that request. The review hasn't begun. No seller can truthfully call retatrutide an approved prescription drug. We won't guess whether approval will come. The retatrutide availability page tells you what's left.

What happened in the first small safety study?

The first small test followed 72 adults with type 2 diabetes. Study doctors raised the weekly amount through 3/6/9/12 mg ^[11]. The highest-amount group lost 8.96 kilograms beyond the loss with placebo after 12 weeks ^[4]. Side effects affected 63 percent of the group. Most were stomach or bowel trouble. No grave problem stopped the work, so Phase 2 could begin.

The Retatrutide research page walks through each later Phase 3 study. The Retatrutide effects page keeps personal reports apart from study findings. The Retatrutide references page links to each paper and federal study listing. You can check the source without knowing a paper's library code.